Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. United Bankshares, Inc.

44% sales growth and 6.82% return on equity

United Bankshares, Inc., a financial holding company, primarily provides commercial and retail banking products and services in the United States.

United Bankshares, Inc.’s sales growth this year is anticipated to be 38.3% and a negative 3.5% for next year.

Year-on-year quarterly revenue growth grew by 69.6%, now sitting on 837.89M for the twelve trailing months.

United Bankshares, Inc.’s sales growth for the next quarter is 44%. The company’s growth estimates for the ongoing quarter and the next is a negative 4.8% and 47.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.82%.

Volatility

United Bankshares, Inc.’s last day, last week, and last month’s average volatility was 3.76%, 0.40%, and 0.31%, respectively.

United Bankshares, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 2.91%, 3.29%, and 2.85%, respectively.

United Bankshares, Inc.’s Stock Yearly Top and Bottom Value

United Bankshares, Inc.’s stock is valued at $31.88 at 01:22 EST, way below its 52-week high of $39.07 and way above its 52-week low of $19.67.

United Bankshares, Inc.’s Moving Average

United Bankshares, Inc.’s value is higher than its 50-day moving average of $29.98 and way higher than its 200-day moving average of $27.06.

2. South Plains Financial, Inc.

20.2% sales growth and 12.14% return on equity

South Plains Financial, Inc. operates as a bank holding company for City Bank that provides commercial and consumer financial services to small and medium-sized businesses and individuals.

South Plains Financial, Inc.’s sales growth this year is anticipated to be 37.7% and a negative 9.3% for next year.

Year-on-year quarterly revenue growth grew by 41.2%, now sitting on 186.39M for the twelve trailing months.

South Plains Financial, Inc.’s sales growth for the next quarter is 20.2%. The company’s growth estimates for the present quarter and the next is 34.5% and 78.9%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.14%.

Volatility

South Plains Financial, Inc.’s last day, last week, and last month’s average volatility was a negative 1.01%, a positive 0.10%, and a negative 0.00%, respectively.

South Plains Financial, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 2.03%, 2.14%, and 2.85%, respectively.

South Plains Financial, Inc.’s Stock Yearly Top and Bottom Value

South Plains Financial, Inc.’s stock is valued at $18.90 at 01:22 EST, way under its 52-week high of $22.00 and way above its 52-week low of $11.30.

South Plains Financial, Inc.’s Moving Average

South Plains Financial, Inc.’s worth is higher than its 50-day moving average of $18.24 and way above its 200-day moving average of $14.94.

3. Charles River Laboratories International, Inc.

8.7% sales growth and 17.28% return on equity

Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery, non-clinical development, and safety testing services.

Charles River Laboratories International, Inc.’s sales growth this year is expected to be 10.2% and 10.3% for next year.

Year-on-year quarterly revenue growth grew by 11.3%, now sitting on 2.82B for the twelve trailing months.

Charles River Laboratories International, Inc.’s sales growth for the next quarter is 8.7%. The company’s growth estimates for the present quarter and the next is 4.5% and 12.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.28%.

Volatility

Charles River Laboratories International, Inc.’s last day, last week, and last month’s average volatility was a negative 1.84%, a negative 0.15%, and a positive 0.42%, respectively.

Charles River Laboratories International, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 3.44%, 2.79%, and 2.23%, respectively.

Charles River Laboratories International, Inc.’s Stock Yearly Top and Bottom Value

Charles River Laboratories International, Inc.’s stock is valued at $247.17 at 01:22 EST, under its 52-week high of $257.88 and way higher than its 52-week low of $95.58.

Charles River Laboratories International, Inc.’s Moving Average

Charles River Laboratories International, Inc.’s value is above its 50-day moving average of $238.63 and way higher than its 200-day moving average of $217.81.

4. Everest Re Group, Ltd.

13.3% sales growth and 7.2% return on equity

Everest Re Group, Ltd., through its subsidiaries, provides reinsurance and insurance products in the United States, Bermuda, and internationally.

Everest Re Group, Ltd.’s sales growth this year is expected to be 16.2% and 11.5% for next year.

Year-on-year quarterly revenue growth grew by 23.1%, now sitting on 8.96B for the twelve trailing months.

Everest Re Group, Ltd.’s sales growth for the next quarter is 13.3%. The company’s growth estimates for the present quarter and the next is 36.6% and 66.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.2%.

Volatility

Everest Re Group, Ltd.’s last day, last week, and last month’s average volatility was 0.45%, 0.20%, and 0.06%, respectively.

Everest Re Group, Ltd.’s last day, last week, and last month’s high and low average amplitude percentage was 1.07%, 1.48%, and 1.84%, respectively.

Everest Re Group, Ltd.’s Stock Yearly Top and Bottom Value

Everest Re Group, Ltd.’s stock is valued at $230.36 at 01:22 EST, way under its 52-week high of $294.31 and way higher than its 52-week low of $157.32.

Everest Re Group, Ltd.’s Moving Average

Everest Re Group, Ltd.’s value is below its 50-day moving average of $233.16 and above its 200-day moving average of $216.68.

5. FirstService Corporation

7.6% sales growth and 14.99% return on equity

FirstService Corporation, together with its subsidiaries, provides residential property services to residential and commercial customers in the United States and Canada.

FirstService Corporation’s sales growth this year is anticipated to be 7.6% and 6.5% for next year.

Year-on-year quarterly revenue growth grew by 10.4%, now sitting on 2.67B for the twelve trailing months.

FirstService Corporation’s sales growth for the next quarter is 7.6%. The company’s growth estimates for the ongoing quarter and the next is 47.1% and 31.1%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.99%.

Volatility

FirstService Corporation’s last day, last week, and last month’s average volatility was 1.62%, 0.57%, and 0.16%, respectively.

FirstService Corporation’s last day, last week, and last month’s high and low average amplitude percentage was 2.68%, 2.75%, and 2.55%, respectively.

FirstService Corporation’s Stock Yearly Top and Bottom Value

FirstService Corporation’s stock is valued at $135.86 at 01:22 EST, below its 52-week high of $145.84 and way higher than its 52-week low of $57.38.

FirstService Corporation’s Moving Average

FirstService Corporation’s worth is higher than its 50-day moving average of $134.86 and way above its 200-day moving average of $122.93.

6. AbbVie

50.4% sales growth and 209.12% return on equity

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the United States, Japan, Germany, Canada, France, Spain, Italy, the Netherlands, the United Kingdom, Brazil, and internationally.

AbbVie’s sales growth this year is anticipated to be 37.2% and 17.9% for next year.

Year-on-year quarterly revenue growth grew by 52.2%, now sitting on 40.65B for the twelve trailing months.

AbbVie’s sales growth for the next quarter is 50.4%. The company’s growth estimates for the present quarter and the next is 29.4% and 18.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 209.12%.

Volatility

AbbVie’s last day, last week, and last month’s average volatility was a positive 1.21%, a positive 0.19%, and a negative 0.01%, respectively.

AbbVie’s last day, last week, and last month’s high and low average amplitude percentage was 1.37%, 1.14%, and 1.96%, respectively.

AbbVie’s Stock Yearly Top and Bottom Value

AbbVie’s stock is valued at $105.27 at 01:22 EST, below its 52-week high of $109.15 and way higher than its 52-week low of $62.55.

AbbVie’s Moving Average

AbbVie’s value is higher than its 50-day moving average of $103.22 and way higher than its 200-day moving average of $95.06.

Previous days news about AbbVie

According to Business Insider on Tue Dec 29,

According to Business Insider on Wed Dec 30,

LEAVE A REPLY

Please enter your comment!
Please enter your name here